Associations between biomarkers of environmental enteric dysfunction and oral rotavirus vaccine immunogenicity in rural Zimbabwean infants

被引:4
作者
Church, James A. [1 ,2 ]
Rukobo, Sandra [1 ]
Govha, Margaret [1 ]
Gough, Ethan K. [1 ,8 ]
Chasekwa, Bernard [1 ]
Lee, Benjamin [3 ]
Carmolli, Marya P. [4 ,5 ]
Panic, Gordana [6 ]
Giallourou, Natasa [6 ]
Ntozini, Robert [1 ]
Mutasa, Kuda [1 ]
McNeal, Monica M. [7 ]
Majo, Florence D. [1 ]
Tavengwa, Naume, V [1 ]
Swann, Jonathan R. [6 ]
Moulton, Lawrence H. [8 ]
Kirkpatrick, Beth D. [4 ,5 ]
Humphrey, Jean H. [1 ,8 ]
Prendergast, Andrew J. [1 ,2 ,8 ]
机构
[1] Zvitambo Inst Maternal & Child Hlth Res, Harare, Zimbabwe
[2] Queen Mary Univ London, Ctr Genom & Child Hlth, Blizard Inst, 4 Newark St, London E1 2AT, England
[3] Univ Vermont, Dept Pediat, Vaccine Testing Ctr, Larner Coll Med, Burlington, VT USA
[4] Univ Vermont, Dept Microbiol, Vaccine Testing Ctr, Larner Coll Med, Burlington, VT USA
[5] Univ Vermont, Dept Mol Genet, Vaccine Testing Ctr, Larner Coll Med, Burlington, VT USA
[6] Imperial Coll London, Fac Med, South Kensington Campus, London SW7 2AZ, England
[7] Univ Cincinnati, Coll Med, Dept Pediat, Div Infect Dis,Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[8] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
基金
比尔及梅琳达.盖茨基金会; 美国国家卫生研究院; 英国惠康基金;
关键词
Infants; Africa; Rotavirus; Oral vaccine; Enteropathy; Environmental enteric dysfunction; GROWTH DEFICITS; SAFETY; INFLAMMATION; ENTEROPATHY; ACQUISITION; TRYPTOPHAN; INFECTION; EFFICACY; ANTIBODY; BINDING;
D O I
10.1016/j.eclinm.2021.101173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Oral rotavirus vaccines (RVV) are poorly immunogenic in low-income countries. Environmental enteric dysfunction (EED) resulting from poor water, sanitation and hygiene (WASH) may contribute. We therefore tested associations between EED and RVV immunogenicity, and evaluated the effect of improved WASH on EED. Methods: We measured nine biomarkers of EED among Zimbabwean infants born to mothers enrolled in a cluster-randomised 2 pound 2 factorial trial of improved WASH and improved feeding between November 2012 and March 2015 (NCT01824940). We used multivariable regression to determine associations between EED biomarkers and RVV seroconversion, seropositivity and geometric mean titer. Log-binomial regression was used to evaluate the effect of improved WASH on EED. Findings: Among 303 infants with EED biomarkers and immunogenicity data, plasma intestinal fatty-acid binding protein and stool myeloperoxidase were positively associated with RVV seroconversion; adjusted RR 1.63 (95%CI 1.04, 2.57) and 1.29 (95%CI 1.01, 1.65), respectively. There were no other associations between RVV immunogenicity and either individual biomarkers or EED domains (intestinal permeability, intestinal damage, intestinal inflammation and microbial translocation). EED biomarkers did not differ between randomised WASH and non-WASH groups. Interpretation: We found no evidence that EED was associated with poor RVV immunogenicity. Contrary to our hypothesis, there was weak evidence that EED was associated with increased seroconversion. EED biomarkers were not affected by a package of household-level WASH interventions. Funding: This work was supported by the Wellcome Trust. The SHINE trial was funded by the Bill & Melinda Gates Foundation; UK Department for International Development (UK Aid); Swiss Agency for Developmentand Cooperation and US National Institutes of Health. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页数:8
相关论文
共 48 条
  • [1] Becker-Dreps S, 2017, PEDIATR INFECT DIS J, V36, P412, DOI [10.1097/inf.0000000000001457, 10.1097/INF.0000000000001457]
  • [2] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [3] Berger S., 2017, VARIOUS VERSATILE VA
  • [4] Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12
    Bernstein, DI
    Smith, VE
    Sherwood, JR
    Schiff, GM
    Sander, DS
    DeFeudis, D
    Spriggs, DR
    Ward, RL
    [J]. VACCINE, 1998, 16 (04) : 381 - 387
  • [5] Soluble CD14 at 2 yr of age: Gender-related effects of tobacco smoke exposure, recurrent infections and atopic diseases
    Carlsen, K. C. Lodrup
    Lovik, M.
    Granum, B.
    Mowinckel, P.
    Carlsen, K. H.
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2006, 17 (04) : 304 - 312
  • [6] Supplementation With Lactoferrin and Lysozyme Ameliorates Environmental Enteric Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Trial
    Cheng, William D.
    Wold, Karl J.
    Bollinger, Lucy B.
    Ordiz, M. Isabel
    Shulman, Robert J.
    Maleta, Kenneth M.
    Manary, Mark J.
    Trehan, Indi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (04) : 671 - 678
  • [7] The Impact of Improved Water, Sanitation, and Hygiene on Oral Rotavirus Vaccine Immunogenicity in Zimbabwean Infants: Substudy of a Cluster-randomized Trial
    Church, James A.
    Rukobo, Sandra
    Govha, Margaret
    Lee, Benjamin
    Carmolli, Marya P.
    Chasekwa, Bernard
    Ntozini, Robert
    Mutasa, Kuda
    McNeal, Monica M.
    Majo, Florence D.
    Tavengwa, Naume V.
    Moulton, Lawrence H.
    Humphrey, Jean H.
    Kirkpatrick, Beth D.
    Prendergast, Andrew J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 69 (12) : 2074 - 2081
  • [8] Exploring the relationship between environmental enteric dysfunction and oral vaccine responses
    Church, James A.
    Parker, Edward P. K.
    Kosek, Margaret N.
    Kang, Gagandeep
    Grassly, Nicholas C.
    Kelly, Paul
    Prendergast, Andrew J.
    [J]. FUTURE MICROBIOLOGY, 2018, 13 (09) : 1055 - 1070
  • [9] Use of the Lactulose to Mannitol Ratio to Evaluate Childhood Environmental Enteric Dysfunction: A Systematic Review
    Denno, Donna M.
    VanBuskirk, Kelley
    Nelson, Zakia C.
    Musser, Christine A.
    Burgess, Deborah C. Hay
    Tarr, Phillip I.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 : S213 - S219
  • [10] Glass RI, 2006, ADV EXP MED BIOL, V582, P45